Clinical Trial Update: M7824 Related Adverse Effects in Adults With Cancer

View source ↗

Summary

An update on adverse effects observed in adults with cancer treated with M7824 (bintrafusp alfa) in an ongoing clinical trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Skin Cancer

Drugs mentioned

• M7824 (bintrafusp alfa)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Neoplasms, Skin Neoplasms | Status: ACTIVE_NOT_RECRUITING